Key facts
- This page summarizes Patrick Marshall's Form 4 filing for Edesa Biotech, Inc. (EDSA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2025, 17:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
On February 12, 2025, the Reporting Person purchased in a private placement, 41,666 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
Footnote F2
Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
Footnote F3
Quidnet Inc. is wholly owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
SEC remarks
Ex. 24 - Power of Attorney